RAC1 and familial pancreatic carcinoma: Mechanistic insights link its activity to Rac1 stimulation, Rho attenuation, and PIK3CD amplification [59, 61], with further implications in tumor–stroma interplay impacting pancreatic cancer resilience and expansion [62].